Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Biofrontera Bioscience GmbH
Biofrontera Bioscience GmbH
Case Comprehensive Cancer Center
Indiana University
Boston Medical Center
Memorial Sloan Kettering Cancer Center
Northwestern University
Northwestern University
Rutgers, The State University of New Jersey